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Abstract
Background: Sleep disturbance is becoming increasingly recognised as a clinically important symptom in people with 
chronic low back pain (CLBP, low back pain >12 weeks), associated with physical inactivity and depression. Current 
research and international clinical guidelines recommend people with CLBP assume a physically active role in their 
recovery to prevent chronicity, but the high prevalence of sleep disturbance in this population may be unknowingly 
limiting their ability to participate in exercise-based rehabilitation programmes and contributing to poor outcomes. 
There is currently no knowledge concerning the effectiveness of physiotherapy on sleep disturbance in people with 
chronic low back pain and no evidence of the feasibility of conducting randomized controlled trials that 
comprehensively evaluate sleep as an outcome measure in this population.
Methods/Design: This study will evaluate the feasibility of a randomised controlled trial (RCT), exploring the effects of 
three forms of physiotherapy (supervised general exercise programme, individualized walking programme and usual 
physiotherapy, which will serve as the control group) on sleep quality in people with chronic low back pain. A 
presenting sample of 60 consenting patients will be recruited in the physiotherapy department of Beaumont Hospital, 
Dublin, Ireland, and randomly allocated to one of the three groups in a concealed manner. The main outcomes will be 
sleep quality (self-report and objective measurement), and self-reported functional disability, pain, quality of life, fear 
avoidance, anxiety and depression, physical activity, and patient satisfaction. Outcome will be evaluated at baseline, 3 
months and 6 months. Qualitative telephone interviews will be embedded in the research design to obtain feedback 
from a sample of participants' about their experiences of sleep monitoring, trial participation and interventions, and to 
inform the design of a fully powered future RCT. Planned analysis will explore trends in the data, effect sizes and 
clinically important effects (quantitative data), and thematic analysis (qualitative data).
Discussion: This study will evaluate the feasibility of a randomised controlled trial exploring the effects of three forms 
of physiotherapy (supervised general exercise programme, individualized walking programme and usual 
physiotherapy, which will serve as the control group) on sleep quality in people with chronic low back pain.
Trial Registration: Current controlled trial ISRCTN54009836
Background
Sleep disturbance is becoming increasingly recognised in
the literature as a clinically important symptom in people
with chronic low back pain (CLBP, low back pain >12
weeks) [1-5]. A large prospective study found there was a
highly significant relationship between pain and sleep (P
< 0.0005), with a 55% increase in the proportion of partic-
ipants reporting restless/light sleep after chronic low
back pain onset [2]. Sleep disturbance has been found to
have a negative effect on mood, pain severity experience
and general quality of life [6,7]. Depression in particular is
strongly associated with disturbed sleep patterns [8,9]
and has been previously identified in sleep studies involv-
ing patients with chronic LBP [10-14]. The pain literature
has shown that lack of sleep or poor quality sleep lowers
the pain threshold and the mental capacity to manage
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pain [15,16], and it has been hypothesized that better
daytime pain control may lead to improved sleep quality
[17]. The current literature has identified that for certain
patients' chronic pain, physical inactivity, sleep disorders
and depression seem to be interdependent, and whether
cause or consequence, LBP-related sleep problems should
be addressed as an integral part of the management plan
of each patient [4].
Current research and international clinical guidelines
recommend people with CLBP to assume a physically
active role in their recovery to prevent chronicity [18-23],
but the high prevalence of sleep disturbance in this popu-
lation may be unknowingly limiting their ability to partic-
ipate in exercise-based rehabilitation programmes and
contributing to poor outcomes. Internationally, physio-
therapy services are frequently utilized by people with
LBP, predominantly for the evidence-based approaches of
advice, spinal manipulative therapy and exercise therapy
[23-28]. However, there is currently no knowledge of the
effectiveness of any physiotherapy approaches for sleep
disturbance in people with chronic low back pain.
While both subjective and objective measures of sleep
patterns have been widely used in sleep research in peo-
ple with various sleep disorders (e.g. obstructive sleep
apnoea and insomnia) for over two decades [29,30], they
have not been previously utilized as outcome measures in
LBP clinical trials. Several valid and reliable subjective
sleep questionnaires are available (e.g. Pittsburgh Sleep
Quality Index [31], Insomnia Severity Index [32]), and the
most widely used objective sleep outcome measure for
research in non-laboratory settings is actigraphy [30].
Recently, other novel non-contact measurement devices
have been developed to measure sleep quality in the
home environment [33,34].
This project will evaluate the feasibility of undertaking
a randomised controlled trial (RCT) that will explore the
effects on subjective and objective measures of sleep
quality and low back pain outcomes, of three forms of
physiotherapy management of low back pain, i.e. a super-
vised general exercise class, usual physiotherapy, and a
novel walking programme. The supervised exercise pro-
gramme is based on the "Back to Fitness" class, whose
effectiveness has been supported in several RCTs, report-
ing significant improvements in pain and disability com-
pared to 'routine' physiotherapy [35] and GP
management [36], with comparable effects to spinal
manipulative therapy [37]. The recent UK National Insti-
tute for Clinical Excellence guideline for persistent LBP
advocates such a structured exercise programme as one
of the cost effective management options for this condi-
tion [23]. Recent literature has identified the need for
research of brief/minimal contact self-activation inter-
ventions, such as walking programmes that encourage
participation in physical activity for CLBP [22,38]. Details
of the walking programme utilized in this feasibility trial
have been reported in detail elsewhere [39].
The objectives are
To determine the most efficient and effective design for
a main RCT by:
• Piloting the methodological procedures
• Determining the recruitment rate and actual numbers
recruited
• Determining attrition rates during the intervention
and follow-up periods
• Completing a qualitative exploration of participants
experience of the trial procedures, interventions, and
outcomes
• Evaluating the feasibility of using equipment to mea-
sure sleep disturbance within a clinical trial setting
• Determining the prevalence of sleep disturbance in
the sample
• Comparing changes in sleep quality, pain, function,
quality of life, fear avoidance, physical activity and patient
satisfaction between groups between baseline and follow-
up
• Exploring the relationship between outcome changes
and sleep quality
• Conducting a power calculation to determine the
numbers needed for a future large-scale, multi-centre,
randomised controlled trial
• Refining the protocol for a future large-scale, multi-
centre, randomised controlled trial
Methods/Design
The Research Ethics Committee of Beaumont Hospital
has granted approval for this study: The trial will be
reported according to the recommendations of the Con-
sort statement [40] and the template for describing the
flow of participants through the study is represented in
Figure 1. The quantitative study will explore the effects of
three forms of physiotherapy (i.e. a supervised general
exercise programme, usual physiotherapy and a walking
programme) on sleep for patients with chronic low back
pain. The qualitative study will explore participants' expe-
rience of the study and the interventions.
Quantitative study
Design
The study will be a prospective feasibility randomized
controlled trial (RCT) with three arms (i) a supervised
exercise class of 8 weeks duration (ii) a walking pro-
gramme of 8 weeks duration and (iii) usual physiotherapy.
Outcomes will be assessed at baseline and 3 [face-to-face]
and 6 month [pre-paid postage] follow-up.
Controlling bias
The RCT design includes key methodological features
that ha ve been recognized as important in minimizing
bias in clinical trials: true randomization, concealed allo-Hurley et al. BMC Musculoskeletal Disorders 2010, 11:70
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Figure 1 Participant flow through the RCT (based on CONSORT statement).
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cation, specification of eligibility criteria, and intention-
to-treat analysis [41].
Setting
A sample of patients will be recruited in Beaumont Hos-
pital physiotherapy department that provides physiother-
apy treatment for people with CLBP in the Northside of
Dublin City.
Protocol protection
The following mechanisms will be used to ensure the trial
protocol is applied consistently: protocol manuals will be
developed and all involved researchers and clinicians will
be trained to ensure that participant screening, assess-
ment, random allocation and treatment procedures are
conducted according to the protocol; a random sample of
10% of treatment records in each group will be audited by
a researcher not involved in the day to day running of the
trial to check that treatment is administered as per the
protocol; if any notable anomalies are found all treatment
records will be checked. The treatment record forms will
be completed by clinicians on every patient recruited to
the study.
Study population and recruitment
Clinics and clinicians
In preparation for the ethical approval and funding appli-
cations for the trial a meeting was held with the relevant
physiotherapy department manager to outline the project
and distribute the outline protocol. Information meetings
were held with the manager and treating physiotherapists
to discuss the study background, aims and methodologies
and to address their queries. Reception staff were briefed
on the study recruitment process, and patient appoint-
ment systems, paperwork and filing arrangements for the
trial were explored.
Prior to commencement of the trial, all participating
physiotherapists involved in the active interventions (i.e.
supervised exercise class, walking programme) will
attend training days in the School of Public Health, Phys-
iotherapy and Population Science, University College
Dublin to be delivered by various members of the
research team. The main focus of the training days will be
to ensure that the interventions are standardized and a
cognitive behavioural therapy (CBT) approach will be
emphasized. In advance of the training days, a detailed
trial manual will be distributed to the therapists and their
role in the study will be highlighted.
Patients
All eligible participants with chronic or recurrent LBP
referred to the Beaumont Hospital physiotherapy depart-
ment by general practitioners or hospital consultants will
be invited to participate in the study by the Trial Co-ordi-
nator in order of referral until the target sample (n = 60)
is achieved (Table 1). They will receive the initial contact
by letter containing the patient information leaflet outlin-
ing the trial procedures and an invitation to attend for
baseline assessment. Suitable, interested participants,
once screened by telephone, will attend the physiotherapy
department, where detailed verbal explanations of the
study protocol will be provided and, written informed
Table 1: Eligibility Criteria
Inclusion criteria Exclusion criteria
Patients with chronic (≥3 
months) or recurrent (≥3 
episodes in previous 12 
months) LBP of mechanical 
origin with/without radiation 
to the lower limb
Clinically diagnosed primary 
sleep disorder e.g sleep 
apnoea, primary insomnia
Males/females between 18-
70 years
Currently or having received 
treatment for CLBP within 
previous 3 months
No spinal surgery within the 
previous 12 months
Patients scoring <10 
indicating minimum 
disability on the Oswestry 
Disability Index
Patients scoring ≥10 
indicating moderate 
disability on the Oswestry 
Disability Index (ODI).
Red flags indicating serious 
spinal pathology, e.g. cancer, 
cauda equina lesion
Patients deemed suitable by 
their GP/hospital consultant 
to carry out an exercise 
programme
Radicular pain indicative of 
nerve root compression
Patients willing to attend for 
an 8-week treatment 
programme of exercise 
classes
Patients diagnosed with 
severe spinal stenosis, 
spondylolisthesis, 
fibromyalgia
Fluency in English (verbal 
and written)
History of systemic/
inflammatory disease, e.g. 
rheumatoid arthritis
Access to a telephone (for 
follow-up support)
Patients with any 
confounding conditions such 
as a neurological disorder or 
currently receiving treatment 
for cancer
Patients with acute (<6 
weeks) or subacute LBP (6-12 
weeks), provided that they 
have experienced <3 LBP 
episodes during previous 12 
months
Unstable angina/
uncontrolled cardiac 
dysrhythmias/severe aortic 
stenosis/acute systemic 
infection accompanied by 
fever
Medico-legal issues
PregnancyHurley et al. BMC Musculoskeletal Disorders 2010, 11:70
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consent will be sought by the Trial Co-ordinator. The
Trial Co-ordinator will record the number of participants
who were invited and declined, those considered ineligi-
ble and the reasons.
Eligibility assessment
Clinicians
Chartered Physiotherapists who are eligible for member-
ship of the Irish Society of Chartered Physiotherapists
and are employed in Beaumont Hospital are eligible to
participate.
Patients
At the baseline interview the Trial Co-ordinator will use a
screening checklist to verify eligibility (Table 1). Written
signed consent will be obtained on all participants. The
Physical Activity Readiness Questionnaire (PAR-Q)[42]
will be completed to determine whether medical clear-
ance is necessary before trial participation.
Randomisation
Consenting participants will be randomly allocated in
accordance with recognised procedures, by a computer-
generated random allocation sequence that will be pre-
pared centrally by the trial statistician (LD). This
sequence will be used to randomly allocate each consent-
ing, numbered participant to one of three study groups
using sealed opaque envelopes: supervised exercise class,
walking programme or usual physiotherapy. Prior to ran-
domisation each participant's group allocation preference
will be sought and recorded by the Trial Co-ordinator in
order to investigate whether treatment preference has any
influence on outcomes.
Following the baseline assessment an appointment for
the relevant intervention will be made by the Trial Co-
ordinator. Each participant will receive a copy of 'The
Back Book'[43] and be advised to read it before the first
physiotherapy appointment.
Blinding
As this is a feasibility study blinding of the outcome asses-
sor will not be possible but for a future main trial the out-
come assessor and trial statistician would be blinded to
group allocation until completion of data analysis. The
Trial Co-ordinator will administer all outcome measures
for face to face and postal follow-up. Due to the nature of
the interventions under investigation it will not be possi-
ble to blind patients or clinicians to their group allocation
in this feasibility study or a future main trial.
Sample Size
No power-based sample size calculation has been carried
out as this study aims to establish the feasibility of con-
ducting a future multi-centre main trial of the same inter-
ventions. Recruitment will be on a consecutive basis, and
will enable the researchers to estimate expected recruit-
ment rates for the main RCT. Based on feasibility, the
researchers aim to recruit 60 participants over a 6 month
period at a rate of 10 per month. Based on the results of
previous trials investigating physiotherapy for LBP [44], a
30% drop-out rate is anticipated between the beginning
of treatment and the follow-up, so it is anticipated that n
= 42 participants will complete the trial.
Outcome measures
A combination of recommended self-report valid and
reliable outcome questionnaires [45] that measure sleep
quality, functional disability, pain, quality of life, physical
activity, psychosocial and work loss variables, as well as
objective measures of sleep quality will be completed at
baseline, 3 month (face to face) and 6 month (postal) fol-
low-up. An evaluation questionnaire regarding the utility
of the objective sleep measures will be completed at base-
line and the satisfaction questionnaire will only be com-
pleted at the 3 month follow-up point.
Baseline Assessment
At baseline, sociodemographic data (i.e. age, gender, edu-
cation level, social status, occupation and work status,
past medical history, LBP history), and any previous
treatment for LBP will be recorded, while blood pressure,
body mass index (BMI, kg/m2), and cardiorespiratory fit-
ness using the shuttle walk test [46], will be measured by
the Trial Co-ordinator. In addition, participants will be
questioned about sleep specific factors which have been
reported in the literature to influence sleep quality i.e.
sleeping place (e.g. bed, chair), environmental noise (e.g.
trains, airport, motorway), mattress firmness and bed-
time, bed sharing, smoking, alcohol or caffeine consump-
tion, painkillers/sleeping tablet use [8,47-53]. Each par-
ticipant will also be asked to indicate their view on the
primary reason for their sleep disturbance.
Sleep quality will be measured using three validated
self-report measures (the Pittsburgh Sleep Quality Index
[31] the Insomnia Severity Index [32] and the Pittsburgh
Sleep Diary [54] and a validated objective measure, the
Actiwatch [30].
Pittsburgh Sleep Quality Index (PSQI)
This is a widely used retrospective questionnaire which
assesses sleep quality and disturbance over the last month
[31,55-57]. Nineteen individual items generate seven
"component scores" (e.g. participantive sleep quality,
sleep latency, sleep duration, sleep efficiency, sleep disor-
ders, use of hypnotics, and poor daytime functioning).
Summation of these scores ('0' no difficulty-'3' severe dif-
ficulty) yields a global score (range 0-21) that indicates a
participants' participantive sleep quality (score of >5
points indicative of sleep disturbance). The PSQI has a
sensitivity of 89.6-98.7% and a specificity of 84.4-86.5%
for identifying cases with a sleep disorder, when the cut-Hurley et al. BMC Musculoskeletal Disorders 2010, 11:70
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off score of >5 points is used. The PSQI will be the main
outcome measure of sleep disturbance.
Insomnia Severity Index (ISI)
This questionnaire has been designed with reference to
the Diagnostic and Statistical Manual for Mental Disor-
ders (DSM-IV) criteria for insomnia and is a reliable and
valid measure containing seven items to quantify per-
ceived insomnia severity (initial, middle, terminal), dis-
satisfaction with current sleep pattern, interference with
daily functioning, noticeability of sleep impairment
attributable to the sleep problem, and degree of distress
or concern raised by the sleep problem [32,58]. The state-
ments are scored on 4-point Likert-scales ('0' not at all -
'4' extremely) generating a total score (range 0-28), indi-
cating clinical insomnia severity (0-7 points no clinically
significant insomnia; 8-14 points subthreshold insomnia;
15-21 points clinical insomnia (moderate); 22-28 points
clinical insomnia (severe)).
Pittsburgh Sleep Diary (PSD)
This is a widely used instrument with eight components,
five of which are completed at bedtime and relate to the
events of the day preceding the sleep (e.g. alcohol, caf-
feine, medication consumption, exercise, 'lights out'), and
three which are completed on wakening that relate to the
sleep period just completed (final wakening time, number
of awakenings, sleep quality) [54]. Participants will be
instructed to report every item every day for 7-nights at
baseline (starting on day of recruitment) and at 3 and 6
month follow-up.
Actiwatch (Model AW4, CamNTech, Cambridge, UK)
This is a small wrist-mounted device (37 × 29 × 10 mm;
16 grams), worn on the non-dominant wrist, which
detects and logs movement intensity and duration by
means of a small piezo-electric accelerometer. Using
sleep analysis software it is capable of evaluating sleep-
wake patterns and common sleep quality variables: i.e.
sleep onset latency, sleep efficiency and sleep fragmenta-
tion. It has been extensively validated against polysom-
nography, the 'gold standard' for sleep studies in healthy
participants [59-62] and those with sleep disorders [63-
65]. The Actiwatches will be set to average activity count
data during recording at 10-sec epochs. Each participant
will be requested to wear the Actiwatch on two separate
occasions each lasting 7 nights as recommended by the
American Academy of Sleep Medicine [66] at (i) baseline
(starting the first night of recruitment), and (ii) 3 month
follow-up either all day or from at least 30 min before
they go to bed until at least 30 min after they wake up.
After each 7-night period of sleep recording, participants
will return the device to Beaumont Hospital in person or
by courier , where data will be downloaded for analysis
using the USB Actiwatch-reader and the Actiwatch Sleep
v7.27 analysis software (CamNTech, Cambridge, UK).
Before analysis, actigraphic data will be automatically
converted to 30-sec epochs by the software and all sleep
episodes will be visually inspected (scale: 1000) to screen
for malfunctioning of the devices and non-wear time.
Oswestry Disability Questionnaire
This is a valid and reliable measure of functional disability
due to low back pain [67]. It consists of ten items, which
measures participants levels of functioning/disability in
various activities of daily living. Each item contains six
statements (0-5 points), of which one has to be chosen.
The total score is converted into a percentage score
(Oswestry Disability Index, ODI) [68] with 0-20% indicat-
ing minimal disability, 21-40% moderate disability, 41-
60% severe disability, 61-80% crippled and 81-100% total
incapacitation.
The ODI will be the main outcome measure of LBP-
related disability.
Numerical Pain Rating Scale
This is a widely used valid and reliable measure of pain,
whereby participants will be requested to choose a num-
ber from 0 (no pain) to 10 (worst possible pain) that best
describes each of the following symptoms: current and
average pain for both back and leg pain [69].
Short-Form 36 Version 2 questionnaire (SF-36v2)
The SF-36v2 (SF-36 Medical Outcomes Trust, Waltham,
MA, USA) [70], is a 36 item valid and reliable measure of
health-related quality of life. It yields an eight scale profile
of functional health and well-being score of which two
standardised summary scores (i.e. Physical Component
Score [PCS] and Mental Component Score [MCS] are
calculated.
Fear-Avoidance Beliefs Questionnaire (FABQ)
This is a 16 item (0-6 scale per item) self-report question-
naire that focuses on participants beliefs about how phys-
ical activity (5 items; 0-30) and work (11 items; 0-66)
affect their low back pain [71].
Hospital Anxiety and Depression Scale (HAD)
This is a widely used self-report questionnaire for detect-
ing overall states of anxiety and depression in non-psy-
chiatric medical contexts [72]. It consists of 14 items
which are statements to be scored on 4-point Likert-
scales (0-3), generating 'Anxiety' or 'Depression' scores
ranging from 0 to 21 (total score = 0-42); which are cate-
gorised as a "non-case" (0-7 points), a "borderline case"
(8-10 points) or a "case" (≥11 points).
International Physical Activity Questionnaire (IPAQ)
This is a self or telephone-administered physical activity
recall questionnaire, which will ask participants about the
time they spent being physically active in the previous
seven days. It has been found to be a valid method for
monitoring population levels of physical activity globally
for populations of 18-69 years of age [73].
Exercise Self Efficacy Questionnaire
Participants will be requested to rate their confidence in
exercising under five different situations (i.e. when tired,Hurley et al. BMC Musculoskeletal Disorders 2010, 11:70
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in a bad mood, limited time, on holiday, bad weather) on
five point Likert scales ranging from 'not at all confident'
to 'extremely confident' [74].
Readiness to Change Questionnaire
Participants will be requested to state their current level
of physical activity participation from one of five possible
responses ranging from 'I currently do not exercise and I
do not intend to start exercising in the next 6 months' to 'I
currently exercise regularly and have done so for longer
than 6 months' [75].
Employment status
The employment status of all participants (employed,
homemaker, carer, unemployed, student, retired, disabil-
ity) and current work status (working, sick leave) of those
in paid employment only will be recorded at each follow-
up point.
Patient Satisfaction Questionnaire
This questionnaire utilises Likert scales to assess partici-
pant satisfaction with outcome and satisfaction with
physiotherapy care during the trial and will be adminis-
tered at the 3 month follow-up point only [76]
Devices Utility Questionnaire
This is 7-item questionnaire designed to establish the
utility (user-friendliness and its difficulties) of the objec-
tive sleep measures, adapted from a previously developed
questionnaire [77]. Acceptability as a sleep measure,
interference with sleep, wearing comfort, and awareness
of wearing the device will be scored on 11-point numeri-
cal rating scales from 0 (not acceptable) to 10 (very
acceptable). Participants will be requested to provide any
free text comments on the use of the objective measures.
Participants will be phoned to request attendance at a
face to face follow-up in the physiotherapy department at
3 months, and pre-paid postage envelopes will be sent at
6 months. Follow-up reminders will be given by phone
and letter. Non-responders to the 3 month face to face
follow-up will be requested to return completed ques-
tionnaires by pre-paid post or by telephone. A courier
will be available to return the sleep monitoring devices
unreturned by patients during the trial.
Interventions
(i) Supervised exercise class (SEC)
Within one week of randomisation, participants will
commence the SEC. This class will follow a group-based
format based on the 'Back to Fitness' programme used in
the UK BEAM trial [37] which is underpinned by cogni-
tive behavioural therapy principles designed to change
participants behaviour by modifying their attitude to
their LBP, i.e. 'hurt' does not mean harm [78,79]. First,
each participant will attend the physiotherapy depart-
ment for an initial individual assessment with the Char-
tered Physiotherapist delivering the class, where there
will be discussion and agreement between the therapist
and the patient on short and long-term goals; recording
of the patient's exercise capabilities and perceived barri-
ers to recovery and the individual's treatment expecta-
tions. Second, participants will attend the physiotherapy
department of the relevant participating hospital once a
week for 8 weeks for a one-hour supervised group exer-
cise class led by a Chartered Physiotherapist. The physio-
therapist will advise patients according to their individual
goals and exercise capabilities, and help identify which
exercise(s) they could continue independently of the
treatment sessions, i.e. foster the development of self-
management strategies. Participants will also be required
to rate their perceived exertion during the class on the
Borg scale - a linear scale measuring level of breathless-
n e s s  f r o m  0  =  ' n o t  b r e a t h l e s s  a t  a l l '  t o  1 0  =  ' m ax i m a l '
[80,81]. Patients will be encouraged to accept responsibil-
ity for determining and carrying out their weekly pro-
gramme of activity. Adherence with the supervised
exercise programme will be recorded as the number of
sessions attended. The number of sessions defined as
adherence will be decided on completion of the trial.
(ii) Walking programme (WP)
Within one week of randomisation, participants will
commence the WP, the focus being to increase physical
activity through a graded walking programme. The WP is
based on previous effective programmes in healthy sed-
entary adults [82-85] and its clinical and cost effective-
ness is currently being evaluated in a multi-centre
randomized controlled trial involving people with
chronic LBP [39].
As with the SEC, each participant will attend the phys-
iotherapy department for an initial individual assessment,
where there will be discussion and agreement between
the therapist and the patient on short and long-term
goals; recording of the patient's exercise capabilities and
perceived barriers to recovery and the individual's treat-
ment expectations. Participants allocated to the WP will
be given an educational walking manual and requested to
record habitual daily activity levels (frequency of walks,
walk duration) an exercise diary prior to the start of the
intervention. Participants will be given an educational
walking manual, and a Yamax Digiwalker Pedometer
Model SW-200 and following instruction in its use
requested to record the number of steps in an exercise
diary. The starting point for the eight week progressive
WP will be a minimum of a 10 minute walk (approx 1200
steps) on at least four days per week to be decided with,
where possible, one day's rest between walks, on the basis
of each participant's normal physical activity levels dur-
ing the first week of recording.
The aim of the programme is to progress to the Ameri-
can College of Sports Medicine guidelines of 30 minutes
moderate intensity walking on five days per week by week
five [86], and then to maintain this level for the remainderHurley et al. BMC Musculoskeletal Disorders 2010, 11:70
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of the programme. The 30 minutes brisk walking may be
accumulated in two or three shorter bouts if this is more
attainable e.g. three 10 minute walks [83,85]. A recent
review found no difference in the positive effects on car-
diovascular fitness of empirical studies of accumulated or
continuous physical activity in sedentary adults and high-
lighted the need for research to evaluate if accumulated
exercise may increase compliance in previously sedentary
adults [87]. All participants will be encouraged to use the
Borg Breathlessness scale to establish their walking
speed: targeting level three (moderate breathlessness) to
four (somewhat severe), the minimum level required to
achieve the benefits related to exercise [80,81].
Participants will then be contacted once per week by
telephone by the Chartered Physiotherapist who per-
formed the initial assessment to progress their walking
frequency and duration based on their exercise diary
r e c o r d  o f  t h e  p r e v i o u s  w e e k ' s  w a l k i n g,  a n d  t o  p r o v i d e
encouragement. These telephone calls will be based
around a telephone script based upon CBT principles,
adapted from a previously developed telephone script for
another LBP clinical trial [88]. Participants will be
advised that just like athletes, any unaccustomed exercise
is likely to produce some muscle soreness [79]. Partici-
pants will be advised to use their pedometer [89] as a
motivational feedback tool, providing immediate infor-
mation on activity levels [90].
Adherence with the walking programme will be
assessed by the frequency, distance, number of steps
taken and duration of walks recorded in the exercise
diary. Specific adherence levels will be established once
the trial is complete. At the end of the intervention par-
ticipants will re-attend the physiotherapy department for
a review appointment with a view to discharge from
physiotherapy.
(iii) Usual Physiotherapy (UP) -Control Group
Within one week of randomization, participants will
commence individual usual physiotherapy at the discre-
tion of the treating physiotherapist. All physiotherapy
treatments and the number of visits will be recorded for
the study period in previously designed treatment record
forms. On the basis of a previous RCT by the Principal
Investigator in the Republic of Ireland public physiother-
apy health service the anticipated mean (SD) number of
treatments is 5.8 over a mean (SD) of 7.7 weeks (5.8)
weeks [91]. A multimodal approach of education/advice,
manipulative therapy and exercise therapy will be permit-
ted on the basis of the results of previous surveys of phys-
iotherapy practice in the UK and Ireland [25-28]. As part
of this it is expected that participants will be provided
with an individualized exercise programme at the discre-
tion of the treating therapist but will not be permitted to
attend group exercise classes or undertake a walking pro-
gramme during the trial. Adherence will be assessed by
the number of visits prior to discharge from physiother-
apy.
Adverse effects or events
No adverse events, apart from minor musculoskeletal
complaints in the WP group, are anticipated but will be
documented by type, length of time, and frequency
should they occur [92].
Data Analysis
All data will be coded and entered into the Statistical
Package for the Social Sciences database for analysis fol-
lowing data cleaning and checking for errors. Since this is
a feasibility study extensive exploratory analysis of the
data will be undertaken. Treatment effects will be repre-
sented by point estimates and confidence intervals of all
outcome variables at all follow-up points. Means and
standard deviations will be used to calculate effect sizes
for the main outcome variables (i.e. PSQI, ODI), and to
undertake a power calculation for the main trial. Monthly
recruitment rates and ratio of number screened: number
enrolled will be tabulated. This information will be used
to help select the recruitment period and number of cen-
tres for the main study. The assessment of patient satis-
faction will be tabulated, as will adherence levels, any
recorded difficulties experienced with the protocol,
including the use of the sleep monitoring equipment or
adverse events experienced by the patients or therapists.
The following criteria would suggest that a main trial is
not feasible: no apparent change in the outcomes with
confidence intervals that include large negative values,
feedback from participants that they were unable/unwill-
ing to complete the outcome measures or adhere to the
intervention, high level of adverse events.
Qualitative study
All participants will receive an invitation letter to partici-
pate in a semistructured telephone interview at the end of
the 6 month follow-up. The telephone interviews will be
conducted by an experienced interviewer with a pre-
determined set of questions. A "clue and process" format
using a checklist of topics, will be used to ensure that the
same basic areas are covered but allowing any issues of
importance to the participants to emerge. The sessions
will be audiotaped, minuted and transcribed verbatim for
independent analysis of emergent themes. The main
areas to be explored will be the effect of back pain on par-
ticipant's sleep, reasons for participation in the trial, their
interpretation of study information and documentation,
their views on the methods of sleep monitoring used in
the trial, their experiences, expectations and satisfaction
with the programme of care including barriers/motiva-
tors to participation in the relevant programme and the
impact of the intervention on sleep.Hurley et al. BMC Musculoskeletal Disorders 2010, 11:70
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Data Analysis
Qualitiative data from the telephone interviews will be
analysed using Burnard's thematic analysis [93]. This pro-
cess aims to produce a systematic and detailed recording
of the themes addressed in the interviews and to link the
themes and interviews together under a reasonably
exhaustive category system. Emerging themes will be
identified and comparisons explored between partici-
pants' experience of trial participation including monitor-
ing of their sleep, their perception of treatment
effectiveness and response to each intervention, its
impact, motivators and barriers to adherence, as well as
their expectations and treatment preferences. A random
sample of transcripts from each group will be selected
and reviewed by an independent researcher not other-
wise involved in the study for inter-rater and intra-rater
reliability of identified themes (trustworthiness, internal
validity).
Discussion
We have presented the rationale and design of a feasibility
randomised controlled trial to evaluate the effectiveness
of three forms of physiotherapy (a supervised general
exercise programme, a walking programme, and usual
physiotherapy) for sleep disturbance in participants with
chronic low back pain. The results of this study will be
presented as soon as they are available.
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